Table 1

Preoperative patient characteristics and procedural comparison

CharacteristicGroup, no (%) or mean ± SD*p value
PG, n = 48PJ, n = 50
Age, yr63.6 ± 13.168.1 ± 10.70.07
Female sex28 (58.33)21 (42)0.11
Biliary instrumentation33 (70.21)36 (72)0.85
Preoperative biopsy27 (57.45)17 (34)0.020
Charlson score, median (IQR)2 (2, 3)2 (2, 3)0.31
Charlson-Age index, median (IQR)4 (3–5)5 (4–6)0.10
ASA score0.07
 116 (33.33)8 (16)
 229 (60.42)34 (68)
 33 (6.25)8 (16)
Weight loss27 (56.25)26 (52)0.67
Jaundice at presentation29 (60.42)39 (78)0.06
Pain at presentation27 (56.25)26 (52)0.67
Duration of surgery, min349 ± 70356 ± 650.64
Estimated blood loss, mL490 ± 305410 ± 2500.12
Gland mobilization, mm31.17 ± 15.4118.35 ± 10.53< 0.001
Stent left in pancreatic duct10 (21.74)39 (82.98)< 0.001
Intraoperative complications1 (2.13)4 (8.16)0.18
Pancreatic duct size, mm3.8 ± 2.44.3 ± 2.60.26
Pancreatic gland texture0.42
 Very soft14 (29.17)12 (26.09)
 Soft11 (22.92)6 (13.04)
 Average14 (29.17)12 (26.09)
 Hard8 (16.67)13 (28.26)
 Very hard1 (2.08)3 (6.52)
Soft pancreatic gland (texture 1 or 2)25 (52.08)18 (39.13)0.21
External drain38 (80.85)44 (91.67)0.13
Epidural anesthesia47 (97.92)48 (96)0.58
Octreotide postoperatively42 (89.36)39 (78)0.13
Blood transfusion5 (10.87)13 (26)0.06
  • ASA = American Society of Anesthesiologists; IQR = interquartile range; PG = pancreaticogastrostomy; PJ = pancreaticojejunostomy; SD = standard deviation.

  • * Unless otherwise indicated.